Ibrutinib Impurity 37 | CAS 330792-69-3 - Request Quote
Ibrutinib Impurity 37
| SZ CAT No: | SZ-I005056 |
| CAS No | 330792-69-3 |
| Mol.F. | C17H12N2O2 |
| Mol.Wt. | 276.3 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Impurity 37 is chemically 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile. Ibrutinib Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 330792-69-3
Purchase 330792-69-3
Order 330792-69-3
Enquire 330792-69-3
price of 330792-69-3
330792-69-3 Supplier
330792-69-3 Manufacturer
330792-69-3 Exporter
buy high quality Ibrutinib Impurity 37
Purchase Ibrutinib Impurity 37
Ibrutinib Impurity 37 suppliers
Ibrutinib Impurity 37 manufacturers
Ibrutinib Impurity 37 price
Order Ibrutinib Impurity 37
Enquire Ibrutinib Impurity 37
Ibrutinib Impurity 37 cost
Ibrutinib Impurity 37 Supplier
Ibrutinib Impurity 37 Distributor
Ibrutinib Impurity 37 for Method Validation
Ibrutinib Reference Standard
Ibrutinib Impurity 37 for ANDA Filing
Ibrutinib Impurity 37 for Forced Degradation Studies
Ibrutinib Impurity 37 Identification Standards
Ibrutinib Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.